BioLineRx Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	39	42	86	415	100	309
Market Cap Growth	-46.99%	-51.17%	-79.39%	314.57%	-67.59%	60.58%
Enterprise Value	26	-4	87	367	-65	126
Last Close Price	0.01	0.02	0.06	0.38	0.14	0.43
Forward PE	-	14.45	14.45	14.45	14.45	14.45
PS Ratio	8.88	11.10	0.81	24.01	-	-
PB Ratio	0.60	0.56	1.75	8.72	0.56	1.46
P/TBV Ratio	38.31	7.17	7.80	-	0.98	2.14
EV/Sales Ratio	5.94	-	0.83	21.22	-	-
Debt / Equity Ratio	0.44	0.44	1.12	0.88	0.24	0.07
Net Debt / Equity Ratio	-0.40	-0.46	-0.34	-2.37	-0.76	-0.77
Net Debt / EBITDA Ratio	0.77	1.07	0.30	0.76	1.36	2.18
Net Debt / FCF Ratio	1.06	1.32	0.10	1.38	1.47	2.22
Asset Turnover	0.03	0.03	0.56	0.07	-	-
Inventory Turnover	0.11	0.09	3.63	-	-	-
Quick Ratio	1.41	1.76	1.52	1.02	4.85	5.89
Current Ratio	1.58	1.95	1.76	1.10	4.87	5.91
Return on Equity (ROE)	-46.72%	-11.01%	-69.11%	-189.23%	-41.96%	-60.04%
Return on Assets (ROA)	-16.55%	-16.11%	-23.28%	-38.30%	-23.10%	-24.07%
Return on Capital Employed (ROCE)	-43.30%	-35.70%	-81.50%	-203.40%	-44.40%	-34.60%
Earnings Yield	-63.47%	-8.97%	-39.26%	-52.59%	-87.63%	-27.24%
FCF Yield	-62.59%	-61.81%	-187.02%	-19.72%	-92.62%	-23.83%
Buyback Yield / Dilution	-73.94%	-105.76%	-24.37%	-24.47%	-16.75%	-162.19%